Evidence map›Paper›PMID 35514148›Full record

ArticleEpidemiology and infection2022

The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally representative retrospective cohort study, 2010-2019.

Darya Pokutnaya, Matthew M Loiacono, Helen Booth, Rachael Williams, Christopher Ma, James Parker, Hélène Bricout, Susan Farrow, Joshua Nealon

Abstract read
In one paragraph

Article in Epidemiology and infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Darya PokutnayaDepartment of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Matthew M LoiaconoGlobal Medical Evidence Generation, Sanofi, Swiftwater, PA, USA.ORCID 0000-0001-8100-465X
Helen BoothClinical Practice Research Datalink (CPRD), Medicines and Healthcare Products Regulatory Agency, London, UK.
Rachael WilliamsClinical Practice Research Datalink (CPRD), Medicines and Healthcare Products Regulatory Agency, London, UK.
Christopher MaUK/IE Medical Affairs, Sanofi, Reading, Berkshire, UK.
James ParkerUK/IE Medical Affairs, Sanofi, Reading, Berkshire, UK.
Hélène BricoutGlobal Medical Evidence Generation, Sanofi, Lyon, France.
Susan FarrowUK/IE Medical Affairs, Sanofi, Reading, Berkshire, UK.
Joshua NealonGlobal Medical Evidence Generation, Sanofi, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of influenza and pneumonia on individuals in clinical risk groups in England has not previously been well characterized. Using nationally representative linked databases (Clinical Practice Research Database (CPRD), Hospital Episode Statistics (HES) and Office for National Statistics (ONS)), we conducted a retrospective cohort study among adults (≥ 18 years) during the 2010/2011-2019/2020 influenza seasons to estimate the incidence of influenza- and pneumonia-diagnosed medical events (general practitioner (GP) diagnoses, hospitalisations and deaths), stratified by age and risk conditions. The study population included a seasonal average of 7.2 million individuals; approximately 32% had ≥1 risk condition, 42% of whom received seasonal influenza vaccines. Medical event incidence rates increased with age, with ~1% of adults aged ≥75 years hospitalized for influenza/pneumonia annually. Among individuals with vs. without risk conditions, GP diagnoses occurred 2-5-fold more frequently and hospitalisations were 7-10-fold more common. Among those with obesity, respiratory, kidney or cardiovascular disorders, hospitalisation were 5-40-fold more common than in individuals with no risk conditions. Though these findings likely underestimate the full burden of influenza, they emphasize the concentration of disease burden in specific age and risk groups and support existing recommendations for influenza vaccination.

Indexed as

Influenza, HumanInfluenza VaccinesPneumoniaAdultAgedEnglandHumansRetrospective StudiesInfluenza VaccinesCo-morbiditiesdisease burdeninfluenzapneumoniaretrospective cohort study

Identifiers

PMID35514148
PMCPMC9171903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.